Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Immune Design Corp. (IMDZ)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/04/2019 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 75,000 shares
@ $5.85, valued at
$438.8k
Disposed/sold 10,000 options to buy
@ $5.6, valued at
$56k
Disposed/sold 12,500 options to buy
@ $4.05, valued at
$50.6k
Disposed/sold 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 04/04/2019 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 78,287 shares
@ $5.85, valued at
$458k
Disposed/sold 3,058 options to buy
@ $1.48, valued at
$4.5k
Disposed/sold 4,281 options to buy
@ $1.23, valued at
$5.3k
Disposed/sold 10,000 options to buy
@ $5.6, valued at
$56k
Disposed/sold 12,500 options to buy
@ $4.05, valued at
$50.6k
Disposed/sold 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 04/04/2019 |
4
| Yurasov Sergey (Sr. VP, Clinic. Devel. & CMO) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 6,136 shares
@ $5.85, valued at
$35.9k
Disposed/sold 72,620 restricted stock units
@ $0
Disposed/sold 110,000 options to buy
@ $4.05, valued at
$445.5k
Disposed/sold 113,335 options to buy
@ $4.4, valued at
$498.7k
Disposed/sold 110,000 options to buy
@ $1.31, valued at
$144.1k
|
|
| 04/04/2019 |
4
| Brady Stephen R (EVP, Strategy & Finance) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 17,063 shares
@ $5.85, valued at
$99.8k
Disposed/sold 79,536 restricted stock units
@ $0
Disposed/sold 116,819 options to buy
@ $1.23, valued at
$143.7k
Disposed/sold 100,000 options to buy
@ $4.05, valued at
$405k
Disposed/sold 184,364 options to buy
@ $4.4, valued at
$811.2k
Disposed/sold 120,000 options to buy
@ $1.31, valued at
$157.2k
|
|
| 04/04/2019 |
4
| Gombotz Wayne (Chief Development Officer) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 37,068 shares
@ $0
Disposed/sold 38,715 options to buy
@ $1.31, valued at
$50.7k
Disposed/sold 6,116 options to buy
@ $1.48, valued at
$9.1k
Disposed/sold 40,697 options to buy
@ $1.23, valued at
$50.1k
Disposed/sold 32,083 options to buy
@ $5.6, valued at
$179.7k
Disposed/sold 11,407 options to buy
@ $4.4, valued at
$50.2k
|
|
| 04/04/2019 |
4
| Paya Carlos V (President and CEO) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 35,576 shares
@ $5.85, valued at
$208.1k
Disposed/sold 121,000 restricted stock units
@ $0
Disposed/sold 195,289 options to buy
@ $1.31, valued at
$255.8k
Disposed/sold 67,277 options to buy
@ $1.31, valued at
$88.1k
Disposed/sold 61,161 options to buy
@ $1.48, valued at
$90.5k
Disposed/sold 244,648 options to buy
@ $1.23, valued at
$300.9k
Disposed/sold 175,000 options to buy
@ $5.6, valued at
$980k
Disposed/sold 216,500 options to buy
@ $4.05, valued at
$876.8k
Disposed/sold 263,009 options to buy
@ $4.4, valued at
$1.2M
Disposed/sold 293,000 options to buy
@ $1.31, valued at
$383.8k
|
|
| 04/04/2019 |
4
| ter Meulen Jan Henrik (Chief Scientific Officer) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 14,620 shares
@ $5.85, valued at
$85.5k
Disposed/sold 69,362 restricted stock units
@ $0
Disposed/sold 98,837 options to buy
@ $1.23, valued at
$121.6k
Disposed/sold 70,000 options to buy
@ $5.6, valued at
$392k
Disposed/sold 90,000 options to buy
@ $4.05, valued at
$364.5k
Disposed/sold 46,788 options to buy
@ $4.4, valued at
$205.9k
Disposed/sold 120,000 options to buy
@ $1.31, valued at
$157.2k
|
|
| 04/04/2019 |
4
| Kelley Susan L. (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 10,000 options to buy
@ $5.6, valued at
$56k
Disposed/sold 12,500 options to buy
@ $4.05, valued at
$50.6k
Disposed/sold 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 04/04/2019 |
4
| PENHOET EDWARD (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 3,058 options to buy
@ $1.48, valued at
$4.5k
Disposed/sold 4,281 options to buy
@ $1.23, valued at
$5.3k
Disposed/sold 10,000 options to buy
@ $5.6, valued at
$56k
Disposed/sold 12,500 options to buy
@ $4.05, valued at
$50.6k
Disposed/sold 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 04/04/2019 |
4
| RINGO WILLIAM R (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 10,000 options to buy
@ $5.6, valued at
$56k
Disposed/sold 12,500 options to buy
@ $4.05, valued at
$50.6k
Disposed/sold 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 04/04/2019 |
4
| COLEMAN LEWIS W (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 175,000 shares
@ $5.85, valued at
$1M
Disposed/sold 3,000 shares
@ $5.85, valued at
$17.6k
Disposed/sold 10,000 options to buy
@ $5.6, valued at
$56k
Disposed/sold 12,500 options to buy
@ $4.05, valued at
$50.6k
Disposed/sold 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 04/02/2019 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Unknown transaction of 6,642,942 shares
@ $5.85, valued at
$38.9M
|
|
| 01/07/2019 |
4
| Paya Carlos V (President and CEO) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 63,000 shares
@ $0
Sold 13,014 shares
@ $1.5822, valued at
$20.6k
Granted 293,000 options to buy
@ $1.31, valued at
$383.8k
|
|
| 01/07/2019 |
4
| ter Meulen Jan Henrik (Chief Scientific Officer) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 25,000 shares
@ $0
Sold 3,414 shares
@ $1.586, valued at
$5.4k
Granted 120,000 options to buy
@ $1.31, valued at
$157.2k
|
|
| 01/07/2019 |
4
| Yurasov Sergey (Sr. VP, Clinic. Devel. & CMO) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 25,000 shares
@ $0
Sold 3,522 shares
@ $1.5717, valued at
$5.5k
Granted 110,000 options to buy
@ $1.31, valued at
$144.1k
|
|
| 01/07/2019 |
4
| Brady Stephen R (EVP, Strategy & Finance) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 25,000 shares
@ $0
Sold 5,516 shares
@ $1.5812, valued at
$8.7k
Granted 120,000 options to buy
@ $1.31, valued at
$157.2k
|
|
| 01/07/2019 |
4
| COLEMAN LEWIS W (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 01/07/2019 |
4
| RINGO WILLIAM R (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 01/07/2019 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 01/07/2019 |
4
| BALTIMORE DAVID (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 01/07/2019 |
4
| Kelley Susan L. (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 01/07/2019 |
4
| PENHOET EDWARD (Director) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 12,500 options to buy
@ $1.31, valued at
$16.4k
|
|
| 12/04/2018 |
4
| BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Sold 430,035 shares
@ $1.8336, valued at
$788.5k
Sold 382,017 shares
@ $1.8336, valued at
$700.5k
Sold 89,948 shares
@ $1.8336, valued at
$164.9k
|
|
| 11/09/2018 |
4
| ter Meulen Jan Henrik (Chief Scientific Officer) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 23,362 shares
@ $0 |
|
| 11/09/2018 |
4
| Brady Stephen R (EVP, Strategy & Finance) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 29,953 shares
@ $0 |
|
| 11/09/2018 |
4
| Yurasov Sergey (Sr. VP, Clinic. Devel. & CMO) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Granted 29,953 shares
@ $0 |
|
| 07/19/2018 |
4
| Brady Stephen R (EVP, Strategy & Finance) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 27,525 options to buy
@ $8.92, valued at
$245.5k
Granted 18,350 options to buy
@ $4.4, valued at
$80.7k
Disposed/sold 12,230 options to buy
@ $8.92, valued at
$109.1k
Granted 8,154 options to buy
@ $4.4, valued at
$35.9k
Disposed/sold 2,838 options to buy
@ $31, valued at
$88k
Granted 1,419 options to buy
@ $4.4, valued at
$6.2k
Disposed/sold 47,162 options to buy
@ $31, valued at
$1.5M
Granted 23,581 options to buy
@ $4.4, valued at
$103.8k
Disposed/sold 50,000 options to buy
@ $13, valued at
$650k
Granted 33,334 options to buy
@ $4.4, valued at
$146.7k
Disposed/sold 5,054 options to buy
@ $19.39, valued at
$98k
|
|
| 07/19/2018 |
4
| Paya Carlos V (President and CEO) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 12,743 options to buy
@ $8.92, valued at
$113.7k
Granted 8,496 options to buy
@ $4.4, valued at
$37.4k
Disposed/sold 66,767 options to buy
@ $8.92, valued at
$595.6k
Granted 44,512 options to buy
@ $4.4, valued at
$195.9k
Disposed/sold 2,450 options to buy
@ $31, valued at
$76k
Granted 1,225 options to buy
@ $4.4, valued at
$5.4k
Disposed/sold 97,550 options to buy
@ $31, valued at
$3M
Granted 48,775 options to buy
@ $4.4, valued at
$214.6k
Disposed/sold 90,000 options to buy
@ $13, valued at
$1.2M
Granted 60,000 options to buy
@ $4.4, valued at
$264k
Disposed/sold 5,471 options to buy
@ $19.39, valued at
$106.1k
|
|
| 07/19/2018 |
4
| Gombotz Wayne (Chief Development Officer) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 6,575 options to buy
@ $31, valued at
$203.8k
Granted 3,288 options to buy
@ $4.4, valued at
$14.5k
Disposed/sold 8,425 options to buy
@ $31, valued at
$261.2k
Granted 4,213 options to buy
@ $4.4, valued at
$18.5k
Disposed/sold 40,000 options to buy
@ $13, valued at
$520k
Granted 26,667 options to buy
@ $4.4, valued at
$117.3k
Disposed/sold 5,906 options to buy
@ $19.39, valued at
$114.5k
Granted 3,375 options to buy
@ $4.4, valued at
$14.9k
Disposed/sold 54,094 options to buy
@ $19.39, valued at
$1M
Granted 30,911 options to buy
@ $4.4, valued at
$136k
|
|
| 07/19/2018 |
4
| ter Meulen Jan Henrik (Chief Scientific Officer) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 2,493 options to buy
@ $31, valued at
$77.3k
Granted 1,247 options to buy
@ $4.4, valued at
$5.5k
Disposed/sold 22,507 options to buy
@ $31, valued at
$697.7k
Granted 11,254 options to buy
@ $4.4, valued at
$49.5k
Disposed/sold 5,574 options to buy
@ $19.39, valued at
$108.1k
Granted 3,186 options to buy
@ $4.4, valued at
$14k
Disposed/sold 54,426 options to buy
@ $19.39, valued at
$1.1M
Granted 31,101 options to buy
@ $4.4, valued at
$136.8k
|
|
| 07/19/2018 |
4
| Yurasov Sergey (Sr. VP, Clinic. Devel. & CMO) has filed a Form 4 on IMMUNE DESIGN CORP.|
Txns:
| Disposed/sold 52,768 options to buy
@ $7.58, valued at
$400k
Granted 35,179 options to buy
@ $4.4, valued at
$154.8k
Disposed/sold 87,232 options to buy
@ $7.58, valued at
$661.2k
Granted 58,155 options to buy
@ $4.4, valued at
$255.9k
Disposed/sold 625 options to buy
@ $5.6, valued at
$3.5k
Granted 417 options to buy
@ $4.4, valued at
$1.8k
Disposed/sold 29,375 options to buy
@ $5.6, valued at
$164.5k
Granted 19,584 options to buy
@ $4.4, valued at
$86.2k
|
|
| 01/08/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2018 |
4
| BERGER FRANKLIN M (Director) has filed a Form 4 on Immune Design Corp.|
Txns:
| Granted 12,500 options to buy
@ $4.05, valued at
$50.6k
|
|
| 01/08/2018 |
4
| RINGO WILLIAM R (Director) has filed a Form 4 on Immune Design Corp.|
Txns:
| Granted 12,500 options to buy
@ $4.05, valued at
$50.6k
|
|
|
|
|